Results 201 to 210 of about 26,575 (260)

Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI). [PDF]

Medicine (Baltimore), 2021
Wan M, Xu H, Li D, Wang L, Li X.
europepmc   +1 more source

Regular Consumption of Green Tea as an Element of Diet Therapy in Drug-Induced Liver Injury (DILI). [PDF]

Nutrients
Winiarska-Mieczan A, Jachimowicz-Rogowska K, Kwiecień M, Borsuk-Stanulewicz M, Tomczyk-Warunek A, Stamirowska-Krzaczek E, Purwin C, Stryjecka M, Tomaszewska M.   +8 more
europepmc   +1 more source

896 THE NATURAL HISTORY OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI): FOLLOW-UP IN A COHORT OF PATIENTS IDENTIFIED IN A SINGLE TERTIARY CARE CENTRE

, 2008
B. García‐Muñoz, Susana López-Ortega, Y. Borraz, Alejandra Fernández Castañer, M. C. López‐Vega, Mercedes Robles‐Díaz, Nicolás Ortíz, Ignacio Cueto, M. Isabel Lucena, Raúl J. Andrade   +9 more
openalex   +1 more source

Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations. [PDF]

Liver Int
Bonkovsky HL, Ghabril M, Nicoletti P, Dellinger A, Fontana RJ, Barnhart H, Gu J, Daly AK, Aithal GP, Phillips EJ, Kleiner DE, US DILIN Investigators.   +11 more
europepmc   +1 more source

A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI). [PDF]

Mol Divers
Mili A, Birangal S, Nandakumar K, Lobo R.   +3 more
europepmc   +1 more source

Potential Drug Induced Liver Injury (Dili) Event During Remdesivir Treatment in Covid-19 Patients

, 2022
Ulvi Nur Rista, Desi Setyowati, Julaeha Julaeha   +2 more
openalex   +1 more source

A case of Dili-drug induced liver injury by norethisterone combined with mifepristone

Chaitanya Indrani, A Shanish Antony
openalex   +1 more source

IQ DILI Consensus Opinion: Best Practices for Rechallenge Following Suspected Drug-Induced Liver Injury in Clinical Trials

Klaudia Steplewski, Lucy S. K. Walker, Nefeteria Coffee, Maura Fallon, Rie Yonemochi, David Alpers, Don C. Rockey, James H. Lewis, Eric Cohen, John Caminis, Judith Hey‐Hadavi, Raúl J. Andrade, Melissa Palmer   +12 more
openalex   +1 more source

A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury [PDF]

, 2015
Abhasnee Sobhonslidsuk, Ammarin Thakkinstian, Chote Luangchosiri, Sermsiri Chitphuk, Supanna Petraksa, Wasana Stitchantrakul   +5 more
core   +1 more source

New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?

Shivangi Shrimali, Minjun Chen, Dongying Li, Weida Tong   +3 more
openalex   +1 more source